Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of Palliative Medicine|September 14, 2020
Differentiating tuberculous pleuritis from other exudative lymphocytic pleural effusionsPichaya Petborom, Bothamai Dechates, Panunat Muangnoi
Frontiers in Endocrinology|July 18, 2024
The existence of adrenal insufficiency in patients with COVID-19 pneumoniaThachanun Porntharukchareon, Bothamai Dechates, Supamas Sirisreetreerux, et al.
Diabetology International|May 9, 2022
Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccineVimonsri Rangsrisaeneepitak, Thachanun Porntharukchareon, Bothamai Dechates, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2024
Skeletal Effect of Parathyroidectomy on Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-AnalysisNattanan Kongsaree, Thanaporn Thanyajaroen, Bothamai Dechates, et al.
BMJ Open Diabetes Research & Care|December 30, 2022
The Effect of high temperature on the stability of basal insulin in a pen: a randomized controlled, crossover, equivalence trialTanawan Kongmalai, Patima Orarachin, Bothamai Dechates, et al.
Vaccines|March 30, 2023
Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare WorkersBothamai Dechates, Thachanun Porntharukchareon, Supamas Sirisreetreerux, et al.
Human Vaccines & Immunotherapeutics|March 4, 2022
Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai populationKriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Scientific Reports|July 21, 2023
Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai populationSupamas Sirisreetreerux, Thachanun Porntharukchareon, Bothamai Dechates, et al.
Human Vaccines & Immunotherapeutics|September 6, 2023
The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort studyThachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, et al.
Pageof 1